Pelthos Therapeutics(PTHS.US)

Event Tracking

Nov25

Roth MKM Analyst Reiterates Buy Rating on Pelthos Therapeutics

05:36

Nov14

Oppenheimer and Alliance Global Partners Maintain Buy Rating on Pelthos Therapeutics

12:57

Nov13

Pelthos Therapeutics released FY2025 9 Months Earnings on November 13 Pre-Market EST, actual revenue USD 7.406 M, actual EPS USD -13.8994

14:30

Pelthos Therapeutics released FY2025 Q3 earnings on November 13 Pre-Market (EST), actual revenue USD 7.406M (forecast USD 6.878M), actual EPS USD -5.3039 (forecast USD -5.3)

14:30

Nov7

Pelthos Therapeutics Inc. Acquires Xepi® to Enhance Dermatology Portfolio

13:03

Nov6

Pelthos Therapeutics to Release FY2025 Q3 Earnings on November 13 Pre-Market EST, Forecast Revenue USD 6.878 M

00:08

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 7.406 M, Net Income -16.24 M, EPS -5.3039

Aug13

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -3.449 M, EPS -5.3846

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -1.968 M, EPS -3.2108

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change